{"id":4415,"date":"2019-03-26T05:01:40","date_gmt":"2019-03-26T05:01:40","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?post_type=study_trials&#038;p=4415"},"modified":"2020-11-03T20:47:02","modified_gmt":"2020-11-03T20:47:02","slug":"etude-sur-la-securite-la-tolerance-et-la-pharmacocinetique-du-dcc-2618-chez-des-patients-atteints-de-tumeurs-malignes-avancees","status":"publish","type":"study_trials","link":"https:\/\/www.erdheim-chester.org\/fr\/study_trials\/a-safety-tolerability-and-pk-study-of-dcc-2618-in-patients-with-advanced-malignancies\/","title":{"rendered":"\u00c9tude sur la s\u00e9curit\u00e9, la tol\u00e9rance et la pharmacocin\u00e9tique du DCC-2618 chez des patients atteints de tumeurs malignes avanc\u00e9es"},"content":{"rendered":"<p><strong>Objectif de l'\u00e9tude :<\/strong>&nbsp; Il s'agit d'un essai de phase I visant \u00e0 \u00e9valuer la s\u00e9curit\u00e9 et l'efficacit\u00e9 du m\u00e9dicament exp\u00e9rimental DCC-2618, administr\u00e9 par voie orale (PO), chez des patients adultes atteints de tumeurs malignes avanc\u00e9es.<br \/>\n<strong>Parrain :<\/strong>&nbsp; Deciphera Pharmaceuticals LLC<br \/>\n<strong>Coordonn\u00e9es pour l'essai :<\/strong>&nbsp; Divya Sakamuri ; 1-713-745-3296 ; dsakamuri@mdanderson.org ou Filip Janku ; 713-563-1930 ; FJanku@mdanderson.org<br \/>\n<strong>Participation demand\u00e9e au patient :<\/strong>&nbsp; Patients atteints d'ECD \u00e2g\u00e9s de 18 ans ou plus.<br \/>\n<strong>Centres connus acceptant des patients atteints d'ECD dans le cadre de l'essai :<\/strong>&nbsp; MD Anderson, Houston, Texas<br \/>\n<strong>Identifiant ClinicalTrials.gov :<\/strong>&nbsp; NCT02571036<\/p>","protected":false},"excerpt":{"rendered":"<p>Study Objective:&nbsp; This is a Phase 1 trial to investigate the safety and efficacy of the investigational drug, DCC-2618, administered orally (PO), in adult patients with advanced malignancies. Sponsor:&nbsp; Deciphera [&hellip;]<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"","wds_primary_study_trials_cat":0,"_links_to":"","_links_to_target":""},"study_trials_cat":[32],"class_list":["post-4415","study_trials","type-study_trials","status-publish","hentry","study_trials_cat-drug-trial"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/study_trials\/4415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/study_trials"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/types\/study_trials"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/media?parent=4415"}],"wp:term":[{"taxonomy":"study_trials_cat","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/study_trials_cat?post=4415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}